Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC’s ‘Final Trades’
Benzinga – by Avi Kapoor, Benzinga Staff Writer.
On CNBC’s “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. (NYSE:PFE) is a gift.
Pfizer is looking to build on the success of its COVID-19 vaccine ro…